Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets in
Multiple-center, Randomized, Double-blind, Placebo-controlled Multiple-dose,
Multiple-administration Study in Patients With Chronic Hepatitis B (CHB)